Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIC with paclitaxel after radical surgery for ovarian peritoneal carcinomatosis
2014-002850-38Phase 2Terminated
- Sponsor
- Fundación para la Investigación Biomédica de Córdoba
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of paclitaxel in ovarian cancer (2 arms), sponsored by Fundación para la Investigación Biomédica de Córdoba. Primary endpoint: Global survival time. Started Oct 2014; status: terminated.
02
Drugs
paclitaxel
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2014-002850-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002850-38.